Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

 

Scripps MD Anderson Cancer Center
Avatar

Thrombosis in Cancer Patients: Vitamin K Antagonists and Direct Oral Anticoagulants Bridge or Interruption?

By Scripps MD Anderson Cancer Center FEATURING James Douketis
By Scripps MD Anderson Cancer Center FEATURING James Douketis
186 views
March 18, 2019
0 Comments
Login to view comments. Click here to Login
Nonmalignant Hematology
15:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Historical Overview of PEX Therapy in TTP

Feat. J. Kelton
13:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Measuring ADAMTS13 Levels in TTP: New Findings

Feat. J. Kelton
13:29
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Update on TTP Treatment: PEX, Antibody or Nanobody?

Feat. J. Kelton
05:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Summary of Hemolytic-Uremic Syndrome in 2019: From Types and Diagnos…

Feat. J. Kelton
28:10
Scripps MD Anderson Cancer Center

Thrombosis in Cancer Patients: Vitamin K Antagonists and Direct Oral…

Feat. J. Douketis
11:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Diagnosing Models for Advanced Systemic Mastocytosis

Feat. J. Gotlib
12:37
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treatment Considerations for Advanced Systemic Mastocytosis

Feat. J. Gotlib
10:00
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Eosinophilia and Eosinophilia-Associated Myeloid/Lymphoid Neoplasms:…

Feat. J. Gotlib
10:22
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treating Eosinophilia-Associated Myeloid/Lymphoid Neoplasms: TKI-Tar…

Feat. J. Gotlib
12:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Best Treatment for VTE in Cancer Patients: DOACs vs. LMWH

Feat. S. Moll
10:45
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

DVT Prophylaxis in Higher-Risk VTE Cancer Patients: Outcomes of AVER…

Feat. S. Moll
09:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

2018/2019 DOACs Update on Obesity, Bariatric Surgery, Antiphospholip…

Feat. S. Moll
17:19
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

How Long and How to Treat VTE? Anticoagulation Therapy, Recurrence T…

Feat. S. Moll
04:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Neutrophilic Leukocytosis: General Testing Algorithm - J…

Feat. B. Reeves
34:00
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Erythrocytosis: General Testing Algorithm - JAK2 and EPO…

Feat. B. Reeves
12:44
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Thrombocytosis: General Testing Algorithm - JAK2, BCR-AB…

Feat. B. Reeves
54:04
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

MGUS: Disease Definitions, Diagnostic Approaches and Risk Stratifica…

Feat. M. Gertz
22:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Gamechanger in Hemophilia Treatment: rVWF, Antibody and Gene Therapy

Feat. A. Ma